Dieter Prechtel

Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b

Andreas Schnelzer, Dieter Prechtel, Ulla G. Knaus et al. · Oncogene · 2000 · 408 citations · Full text

Systems Biology, Oncology, Engineering +14

Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

Barbara Schmalfeldt, Dieter Prechtel, Kathrin Härting et al. · PubMed · 2001 · 336 citations

Protease Inhibitors, Tumoral Pathology, Oncology +14

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu

Ernst Lengyel, Dieter Prechtel, James H. Resau et al. · International Journal of Cancer · 2004 · 267 citations

Signal Transduction Pathways, Breast Oncology, Poor Clinical Outcome +17

Expression of Latent Matrix Metalloproteinase 9 (MMP-9) Predicts Survival in Advanced Ovarian Cancer

Ernst Lengyel, Barbara Schmalfeldt, Elisabeth Konik et al. · Gynecologic Oncology · 2001 · 112 citations

Advanced Ovarian Cancer, Medicine, Pathology +7

Clinical Relevance of T1-S, an Oncogene-Inducible, Secreted Glycoprotein of the Immunoglobulin Superfamily, in Node-Negative Breast Cancer

Dieter Prechtel, Nadia Harbeck, Ursula Berger et al. · Laboratory Investigation · 2001 · 11 citations · Full text

Secreted Glycoprotein, Breast Oncology, Cancer Immunosurveillance +8